Table 3.
More stringent target (< 6.5%) |
Short diabetes duration |
Long life expectancy |
T2DM treated with lifestyle or metformin only |
No significant CVD/vascular complications |
Less stringent target (< 8.0%) |
Severe hypoglycaemia history |
Limited life expectancy |
Advanced microvascular or macrovascular complications |
Extensive comorbidities |
Long-term diabetes in whom general HbA1c targets are difficult to attain |
Targets may be individualized based on: |
Age/life expectancy |
Comorbid conditions |
Diabetes duration |
Hypoglycaemia status |
Individual patient considerations |
1More or less stringent targets may be appropriate for individual patients if achieved without significant hypoglycaemia. CVD: Cardiovascular disease; T2DM: Type 2 diabetes mellitus; HbA1c: Glycated hemoglobin.